- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Harrow Health Inc (HROW)
Harrow Health Inc stock price live, this page displays NASDAQ HROW stock exchange data. View the HROW premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Harrow Health Inc real time stock price chart below.
What Is the Harrow Health Inc Stock Price Today?
The Harrow Health Inc stock price today is 38.820.
What Is the Stock Symbol for Harrow Health Inc?
The stock symbol for Harrow Health Inc is ""HROW.""
What Stock Exchange Does Harrow Health Inc Trade On?
Harrow Health Inc is listed and trades on the NASDAQ stock exchange.
Is Harrow Health Inc a Good Stock to Buy?
Determining whether Harrow Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HROW quote. (ISIN: US4158581094)
What Is the Harrow Health Inc Stock Price Today?
The Harrow Health Inc stock price today is 38.820.
What Is the Stock Symbol for Harrow Health Inc?
The stock symbol for Harrow Health Inc is ""HROW.""
What Stock Exchange Does Harrow Health Inc Trade On?
Harrow Health Inc is listed and trades on the NASDAQ stock exchange.
Is Harrow Health Inc a Good Stock to Buy?
Determining whether Harrow Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HROW quote. (ISIN: US4158581094)
NASDAQ
Currency in USD
Fair Value
An estimate of a Harrow Health's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.700
40.610
52 wk Range
20.850
59.230
HROW Scorecard
Full Analysis
Net income is expected to grow this year
HROW is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Harrow Health's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.70040.610
52 wk Range
20.85059.230
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HROW Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Harrow Health's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
59.775
Upside
+53.98%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Harrow Health Inc Company Profile
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.
Harrow Health Inc Earnings Call Summary for Q2/2025
- Harrow Health's Q2 2025 EPS of $0.24 significantly beat $0.01 forecast; revenue up 30% YoY to $63.7M, missing $66M estimate
- Stock rose 6.99% in premarket trading despite revenue shortfall; company maintains 74.53% gross margin
- Strong performance in product lines like VeeVai and iHizo; strategic acquisitions bolster ophthalmic market position
- 2025 revenue guidance maintained at over $280M; plans for biosimilar launch in 2026 and manufacturing expansion
- CEO highlights profitability of VeeVai prescriptions and substantial market opportunity ahead
Last Updated: 12/08/2025, 14:30
Read Full TranscriptCompare HROW to Peers and Sector
Metrics to compare | HROW | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHROWPeersSector | |
|---|---|---|---|---|
P/E Ratio | −140.4x | −0.1x | −0.5x | |
PEG Ratio | −2.00 | 0.26 | 0.00 | |
Price/Book | 28.9x | 2.3x | 2.6x | |
Price / LTM Sales | 6.3x | 1.6x | 3.3x | |
Upside (Analyst Target) | 61.0% | 60.3% | 40.3% | |
Fair Value Upside | Unlock | 10.8% | 5.1% | Unlock |
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 59.775
(+53.98% Upside)
Earnings
Latest Release
Aug 11, 2025
EPS / Forecast
0.24 / 0.01
Revenue / Forecast
63.70M / 66.00M
People Also Watch
FAQ
What Stock Exchange Does Harrow Health Trade On?
Harrow Health is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Harrow Health?
The stock symbol for Harrow Health is "HROW."
What Is the Harrow Health Market Cap?
As of today, Harrow Health market cap is 1.44B.
What Is Harrow Health's Earnings Per Share (TTM)?
The Harrow Health EPS (TTM) is -0.28.
When Is the Next Harrow Health Earnings Date?
Harrow Health will release its next earnings report on 16 Nov 2025.
From a Technical Analysis Perspective, Is HROW a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Harrow Health Stock Split?
Harrow Health has split 3 times.
How Many Employees Does Harrow Health Have?
Harrow Health has 382 employees.
What is the current trading status of Harrow Health (HROW)?
As of 16 Aug 2025, Harrow Health (HROW) is trading at a price of 38.82, with a previous close of 40.01. The stock has fluctuated within a day range of 37.70 to 40.61, while its 52-week range spans from 20.85 to 59.23.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.